Chongqing Medical University has successfully developed COVID-19 antibody testing kit (magnetic particle-based chemiluminescence immunoassay) in cooperation with Bioscience (Chongqing) Diagnostic Technology Co., Ltd. The testing kit gained approval for clinical use by National Medical Products Administration on March 1, 2020. It is the first COVID-19 antibody testing kit using chemiluminescence that enters China's market. On March 9, seven of the testing kits received the CE certification, an official approval to enter the European market.
